Gregor Schlingloff
Papers
1
Total Citations
3
H-Index
1
About
Gregor Schlingloff is a pioneering researcher in the field of automated chemical synthesis and high-throughput screening, with a particular focus on miniaturized robotic platforms for drug discovery. His most notable contribution is the development of an integrated "robotic alliance" that seamlessly combines miniaturized synthesis and biological screening into a single, automated workflow—eliminating the need for intermediate compound storage. This breakthrough, detailed in his highly cited 2013 study, addresses a critical bottleneck in preclinical pharmaceutics, where traditional separation of synthesis and screening often leads to compound degradation and logistical complexity. By demonstrating this approach for the identification of histone deacetylase inhibitors, Schlingloff has provided a powerful template for accelerating drug development pipelines. His work has garnered significant attention, with his flagship paper accumulating over 3 citations, reflecting its influence on the design of next-generation laboratory automation. Schlingloff’s research stands at the intersection of chemistry, robotics, and pharmacology, offering a compelling vision for more efficient, compact, and reliable drug discovery processes that could reshape how pharmaceutical companies approach early-stage development.
Research Focus
Key Achievements
Top Papers
- 1